Welcome to HCV Advocate’s hepatitis blog. The intent of this blog is to keep our website audience up-to-date on information about hepatitis and to answer some of our web site and training audience questions. People are encouraged to submit questions and post comments.
For more information on how to use this blog click here, the HCV drug pipeline click here, and for more information on HCV clinical trials click here
Friday, November 18, 2011
Viral Hepatitis Action Plan: Spotlight on Hepatitis B
Successful implementation of the Viral Hepatitis Action Plan could result in a substantial increase in the proportion of individuals aware of their hepatitis B infection from the current level of 33% thereby enabling them to seek treatment as well as reduce transmission of the virus to others. The Action Plan calls for health care providers to become better aware of opportunities for preventing, treating, and caring for viral hepatitis, including HBV infections. By strengthening the capacity of state and local health departments to collect a core set of viral hepatitis surveillance data we can better monitor trends in disease and the long-term impact of prevention, care and treatment. In addition, the Plan aims to eliminate the transmission of hepatitis B from mother to child by, among other actions, ensuring that hospitals and birthing centers administer a “birth dose” of hepatitis B vaccine to all newborns prior to discharge.